Skip to main content

Table 1 Characteristics of patients in the study

From: Results of a phase II open-label, non-randomized trial of cisplatin chemotherapy in patients with BRCA1-positive metastatic breast cancer

Age, years

 

   Mean (range)

48.0 (32 to 70)

Type of BRCA1 mutation

 

5382insC

13

C61G

6

153delA

1

Year of initial treatment

 

2000 to 2003

2

2004 to 2006

7

2007 to 2009

11

Estrogen receptor

 

   Positive

5

   Negative

15

Progesterone receptor

 

   Positive

3

   Negative

17

HER2 status

 

   Positive

0

   Negative

20

Histology

 

   Ductal

11

   Medullary

7

   Other

1

   Missing

1

Prior adjuvant chemotherapy

 

Yes

13

No

7

Sites of metastases

 

Liver

10

Lung

9

Bone

3

Other

11

Number of sites of metastases

 

1

12

2

4

3

2

4+

2

Prior chemotherapy for metastatic disease

 

Yes

11

No

9

Line of therapy of metastatic disease

 

1

9

2

2

3

8

4

1